BiotechTube
Home/Fountain Therapeutics/Thomas Rando, M.D., Ph.D.
TR

Thomas Rando, M.D., Ph.D.

Founder, Executive Chair of the Board

Fountain Therapeutics

Therapeutic Areas

Dermatology/AestheticsMusculoskeletalGerontology

Fountain Therapeutics Pipeline

DrugIndicationPhase
FTX002600/FTX003059 Topical CombinationSkin Atrophy (age- and weight loss-associated)Preclinical
FTX008762Sarcopenia and GLP-1 agonist-induced lean tissue atrophyPreclinical

Leadership Team at Fountain Therapeutics

JT
Joseph T Rodgers, Ph.D.
Co-Founder, Scientific and Technical Lead
View full Fountain Therapeutics profile